Corrigendum to: Expression of Concern: HMGB 1 mediates splenomegaly and expansion of splenic CD 11b+ L y-6 Chigh inflammatory monocytes in murine sepsis survivors (Journal of Internal Medicine, (2013), 274, 4, (381-390), 10.1111/joim.12104);HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6Chigh inflammatory monocytes in murine sepsis survivors

Journal of Internal Medicine

Volumn 274, Issue 4, 2013, Pages 381-390

  Valdes Ferrer S I ^a,b   Rosas Ballina, M ^c   Olofsson, P S ^a   Lu, B ^a,b   Dancho, M E ^a   Ochani, M ^a   Li, J H ^a   Scheinerman, J A ^a   Katz, D A ^a   Levine, Y A ^d   Hudson, L K ^a   Yang, H ^a   Pavlov, V A ^a   Roth, J ^a   Blanc, L ^a   Antoine, D J ^e   Chavan, S S ^a   Andersson, U ^f   Diamond, B ^a   Tracey, K J ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b Elmezzi Graduate School of Molecular Medicine   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

^d SetPoint Medical Valen Inc   (United States)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anti HMGB1; HMGB1; Sepsis survivors; Splenomegaly

Indexed keywords

CD11B ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CELL EXPANSION; CONTROLLED STUDY; LEUKOCYTOSIS; LIGATION; MALE; MASS SPECTROMETRY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCTURE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SPLENOMEGALY; SURVIVOR;

EID: 84883739626     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.13061     Document Type: Erratum

References (27)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-10.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54.
3. Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc 2012; 60: 1070-7.
4. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 2003; 31: 2316-23.
5. Williams TA, Dobb GJ, Finn JC et al. Determinants of long-term survival after intensive care. Crit Care Med 2008; 36: 1523-30.
6. Fabry Z, Fitzsimmons KM, Herlein JA, Moninger TO, Dobbs MB, Hart MN. Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J Neuroimmunol 1993; 47: 23-34.
7. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010; 304: 1787-94.
8. Chavan SS, Huerta PT, Robbiati S et al. HMGB1 Mediates Cognitive Impairment in Sepsis Survivors. Mol Med 2012; 18: 930-7.
9. Angus DC, Yang L, Kong L et al. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med 2007; 35: 1061-7.
10. Li J, Wang H, Mason JM et al. Recombinant HMGB1 with cytokine-stimulating activity. J Immunol Methods 2004; 289: 211-23.
11. Qin S, Wang H, Yuan R et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 2006; 203: 1637-42.
12. Yang H, Ochani M, Li J et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004; 101: 296-301.
13. Wang H, Bloom O, Zhang M et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-51.
14. van Zoelen MA, Yang H, Florquin S et al. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 2009; 31: 280-4.
15. Venereau E, Casalgrandi M, Schiraldi M et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 2012; 209: 1519-28.
16. Antoine DJ, Williams DP, Kipar A et al. High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. Toxicol Sci 2009; 112: 521-31.
17. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009; 325: 612-6.
18. Rosas-Ballina M, Goldstein RS, Gallowitsch-Puerta M et al. The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol Med 2009; 15: 195-202.
19. Yang H, Lundback P, Ottosson L et al. Redox modification of cysteine residues regulates the cytokine activity of HMGB1. Mol Med 2012; 18: 250-9.
20. Lu B, Nakamura T, Inouye K et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012; 488: 670-4.
21. Pozo AL, Godfrey EM, Bowles KM. Splenomegaly: investigation, diagnosis and management. Blood Rev 2009; 23: 105-11.
22. Delano MJ, Scumpia PO, Weinstein JS et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007; 204: 1463-74.
23. Osler W, Remarks ON. The Functions of an out-patient department: made at the opening of the new out - patient department, Cardiff infirmary, May 20th, 1908. Br Med J 1908; 1: 1470-1.
24. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 1997; 277: 1058-63.
25. Angus DC. The lingering consequences of sepsis: a hidden public health disaster? JAMA 2010; 304: 1833-4.
26. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005; 33: 564-73.
27. Rosas-Ballina M, Ochani M, Parrish WR et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008; 105: 11008-13.